Form 4: Shattuck Labs Director Neil Gibson Granted 33,150 Stock Options

Shattuck Labs, Inc. Director Neil W. Gibson was granted options to purchase 33,150 shares of common stock at an exercise price of $0.82 per share, vesting based on continued service.

Summary

• Neil W. Gibson, a Director of Shattuck Labs, Inc. (STTK), was granted a stock option on July 14, 2025.
• The option allows the purchase of 33,150 shares of the Issuer's common stock at an exercise price of $0.82 per share.
• The options will vest in full on the earlier of the one-year anniversary of the grant date (July 14, 2026) or immediately prior to the Issuer's next annual meeting of stockholders.
• Vesting is contingent upon Mr. Gibson's continued service to Shattuck Labs, Inc.
• The options have an expiration date of July 14, 2035.
• Following this transaction, Mr. Gibson beneficially owns 33,150 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The grant of stock options to a director is generally a positive signal, aligning interests and incentivizing long-term performance. While it doesn't reflect immediate financial results, it indicates continued commitment from leadership. The low exercise price is also a positive for the recipient, suggesting potential for future gains.

Positives

• The granting of stock options to a director aligns management's interests with shareholders, incentivizing long-term performance and value creation.
• The exercise price of $0.82 per share is relatively low, indicating potential for significant upside if the stock price appreciates.
• The 10-year expiration date (July 14, 2035) provides a long window for the options to become in-the-money and be exercised.

Negatives

• The options are not immediately exercisable and are subject to a vesting schedule, meaning the director does not yet fully own the underlying shares.
• The ultimate value of the options is dependent on the future performance of Shattuck Labs' stock price, which carries inherent market risk.

Risks

• Continued Service Condition: The vesting of the options is subject to Neil W. Gibson's continued service to Shattuck Labs, Inc., meaning the options could be forfeited if service ceases before vesting.
• Stock Price Volatility: The value of the stock options is directly tied to the market price of Shattuck Labs' common stock, which can fluctuate significantly, potentially rendering the options worthless if the stock price does not rise above the exercise price.
• Potential Dilution: Upon exercise, these options will result in the issuance of new shares, which could lead to minor dilution of the ownership percentage of existing shareholders.

Future Outlook

The grant of stock options to a director suggests a long-term commitment to the company's future performance, as the options' value is tied to future stock price appreciation. This aligns the director's financial incentives with the company's long-term success.

Industry Context

The granting of stock options to directors is a standard practice across various industries, particularly in biotechnology and technology sectors, to align the interests of leadership with long-term shareholder value creation. This practice is consistent with typical compensation structures for board members in publicly traded companies.

Stakeholder Impact

• Shareholders: Potential for minor dilution upon exercise of options, but also potential for increased long-term value creation due to aligned director incentives.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The stock option will vest on the earlier of July 14, 2026, or immediately prior to the Issuer's next annual meeting of stockholders, subject to continued service.
• Neil W. Gibson may exercise the vested options to purchase common stock at $0.82 per share at any time before July 14, 2035.

Key Dates

Recommendation

Keywords

Shattuck Labs, STTK, Stock Option, Director Compensation, SEC Form 4, Insider Transaction, Equity Grant, Vesting, Common Stock